Literature DB >> 12053018

Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?

Graeme J Hankey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12053018     DOI： 10.1161/01.str.0000016922.22707.27

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  9 in total

Review 1.  Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke.

Authors:  Sujoy Ghosh; Arjun Kumar Ghosh; Sandip Kumar Ghosh
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

Review 2.  Stenting in Intracranial Stenosis: Current Controversies and Future Directions.

Authors:  Arindam R Chatterjee; Colin P Derdeyn
Journal:  Curr Atheroscler Rep       Date:  2015-08       Impact factor: 5.113

Review 3.  Aspirin and clopidogrel for prevention of ischemic stroke.

Authors:  Ruth M Thomson; David C Anderson
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

Review 4.  Cryptogenic stroke: how to define it? How to treat it?

Authors:  Ava L Liberman; Shyam Prabhakaran
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

5.  Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.

Authors:  Elisa Grifoni; Davide Giglio; Giulia Guazzini; Eleonora Cosentino; Ester Latini; Alessandro Dei; Attilio Del Rosso; Vincenzo Guarnaccia; Mariella Baldini; Maria Letizia Bartolozzi; Pietro Martinucci; Francesca Sani; Antonio Giordano; Francesca Dainelli; Francesca Maggi; Chiara Giulietti; Mario Romagnoli; Stefano Cinotti; Elena Schipani; Giuseppe Salvatore Murgida; Stefania Di Martino; Andrea Cozzi; Adele Carli Ballola; Debora Dacomo; Debora Valori; Luca Masotti
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

Review 6.  Antithrombotic and thrombolytic therapy for ischemic stroke.

Authors:  Curtis Benesch
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

7.  Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.

Authors:  Tao Wang; Jichang Luo; Xue Wang; Kun Yang; Vikram Jadhav; Peng Gao; Yan Ma; Na Zhao; Liqun Jiao
Journal:  Cochrane Database Syst Rev       Date:  2020-08-11

8.  Clarion call for histopathological clot analysis in "cryptogenic" ischemic stroke: implications for diagnosis and treatment.

Authors:  Sonu Bhaskar; Dennis Cordato; Cecilia Cappelen-Smith; Andrew Cheung; David Ledingham; David Celermajer; Christopher Levi
Journal:  Ann Clin Transl Neurol       Date:  2017-11-12       Impact factor: 4.511

9.  Complex Left Atrial Appendage Morphology Is an Independent Risk Factor for Cryptogenic Ischemic Stroke.

Authors:  Indranill Basu-Ray; Deepthi Sudhakar; Gregory Schwing; Dominique Monlezun; Lucy Zhang; Sumit K Shah; Deep Pujara; Kevin Ting; Nidal Abi Rafeh; Gholam Ali; Mark Cassidy; Kenneth Ellenbogen; Glen Levine; Wilson Lam; Nilesh Mathuria; Mohammad Saeed; Jared Bunch; Sheryl Martin-Schild; Michael Gold; Arash Aryana; Mehdi Razavi; Abdi Rasekh
Journal:  Front Cardiovasc Med       Date:  2018-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.